Men with negative results of guaiac-based fecal occult blood test have higher prevalences of colorectal neoplasms than women with positive results

International Journal of Cancer

Volumn 134, Issue 12, 2014, Pages 2927-2934

  Brenner, Hermann ^a   Hoffmeister, Michael ^a   Birkner, Berndt ^b,c   Stock, Christian ^a,d  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b Gastroenterological Practice   (Germany)

^c Association of Statutory Health Insurance Physicians Bavaria   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

colorectal cancer; early detection; fecal occult blood test; prevalence; screening

Indexed keywords

GUAIAC;

ADULT; ADVANCED CANCER; AGE DISTRIBUTION; AGED; ARTICLE; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; DATA ANALYSIS; DISEASE ASSOCIATION; FECES ANALYSIS; FEMALE; FOLLOW UP; GERMANY; HUMAN; IMMUNOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL ANALYSIS; MIDDLE AGED; OCCULT BLOOD TEST; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE;

COLORECTAL CANCER; EARLY DETECTION; FECAL OCCULT BLOOD TEST; PREVALENCE; SCREENING;

AGED; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; GUAIAC; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; PREVALENCE; SENSITIVITY AND SPECIFICITY;

EID: 84897980642     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28618     Document Type: Article

References (38)

1. Mandel JS, Church TR, Ederer F, et al. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst 1999; 91: 434-7.
2. Jørgensen OD, Kronborg O, Fenger C,. A randomised study of screening and colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds. Gut 2002; 50: 29-32.
3. Scholefeld JH, Moss S, Sufi F, et al. Effect of faecal occult blood screening on mortality from colorectal cancer: results from a randomised controlled trial. Gut 2002; 50: 840-4.
4. Hewitson P, Glasziou P, Watson E, et al. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol 2008; 103: 1541-9.
5. Scholefeld JH, Moss SM, Mangham CM, et al. Nottingham trial of faecal occult blood testing for colorectal cancer: a 20-year follow-up. Gut 2012; 61: 1036-40.
6. Zavoral M, Suchanek S, Zavada F, et al. Colorectal cancer screening in Europe. World J Gastroenterol 2009; 15: 5907-15.
7. Regula J, Rupinski M, Kraszewska E, et al. Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia. N Engl J Med 2006; 355: 1863-72.
8. Brenner H, Altenhofen L, Hoffmeister M,. Sex, age and birth cohort effects in colorectal neoplasms: a cohort analysis. Ann Intern Med 2010; 102: 1411-4.
9. Abotchie PN, Vernon SW, Du XL,. Gender differences in colorectal cancer incidence in the United States, 1975-2006. J Women's Health 2012; 21: 393-400.
10. Pox CP, Altenhofen L, Brenner H, et al. Efficacy of a nationwide screening colonoscopy program for colorectal cancer. Gastroenterology 2012; 142: 1460-7.
11. Schmiegel W, Reinacher-Schick A, Arnold D, et al. Update S3 guidelines colorectal cancer 2008. Z Gastroenterol (in German) 2008; 46: 799-840.
12. Qaseem A, Denberg TD, Hopkins RH, Jr, et al. Screening for colorectal cancer: a guidance statement from the American College of Physicians. Ann Intern Med 2012; 156: 378-86.
13. Mansmann U, Crispin A, Henschel V, et al. Epidemiology and quality control of 245 000 outpatient colonoscopies. Dtsch Arztebl Int 2008; 105: 434-40.
14. Crispin A, Birkner B, Munte A, et al. Process quality and incidence of acute complications in a series of more than 230,000 outpatient colonoscopies. Endoscopy 2009; 41: 1018-25.
15. Kolligs FT, Crispin A, Munte A, et al. Risk of advanced colorectal neoplasia according to age and gender. PLoS One 2011; 6: e20076.
16. Stock C, Hoffmeister M, Birkner B, et al. Performance of additional colonoscopies and yield of neoplasms within 3 years after screening colonoscopy: a historical cohort study. Endoscopy 2013; 45: 537-46.
17. Imperiale TF, Ransohoff DF, Itzkowitz SH, et al. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med 2004; 351: 2704-14.
18. Hundt S, Haug U, Brenner H,. Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection. Ann Intern Med 2009; 150: 162-9.
19. Haug U, Hundt S, Brenner H,. Quantitative immunochemical fecal occult blood testing for colorectal adenoma detection: evaluation in the target population of screening and comparison with qualitative tests. Am J Gastroenterol 2010; 105: 682-90.
20. Park DI, Ryu S, Kim H, et al. Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening. Am J Gastroenterol 2010; 105: 2017-25.
21. Rozen P, Comaneshter D, Levi Z, et al. Cumulative evaluation of a quantitative immunochemical fecal occult blood test to determine its optimal clinical use. Cancer 2010; 116: 2115-25.
22. Duffy MJ, van Rossum LGM, van Turenhout ST, et al. Use of fecal markers in screening for colorectal neoplasia: an European group on tumor markers position paper. Int J Cancer 2011; 128: 3-11.
23. Imperiale TF,. Noninvasive screening tests for colorectal cancer. Dig Dis 2012; 30 (Suppl 2): 16-26.
24. Brenner H, Haug U, Hundt S,. Sex differences in performance of fecal occult blood testing. Am J Gastroenterol 2010; 105: 2457-64.
25. Brenner H, Haug U, Hundt S,. Inter-test agreement and quantitative cross-validation of immunochromatographical fecal occult blood tests. Int J Cancer 2010; 127: 1643-9.
26. Rao SK, Schilling TF, Sequist TD,. Challenges in the management of positive fecal occult blood tests. J Gen Intern Med 2009; 24: 356-60.
27. Choi KS, Lee HY, Jun JK, et al. Adherence to follow-up after a positive fecal occult blood test in an organized colorectal cancer screening program in Korea, 2004-2008. J Gastroenterol Hepatol 2012; 27: 1070-7.
28. Stock C, Ihle P, Schubert I, et al. Colonoscopy and fecal occult blood test use in Germany: results from a large insurance-based cohort. Endoscopy 2011; 43: 771-9.
29. Van Rijn JC, Reitsma JB, Stoker J, et al. Polyp miss rate determined by tandem colonoscopy: a systematic review. Am J Gastroenterol 2006; 101: 343-50.
30. Stock C, Brenner H,. Utilization of lower gastrointestinal endoscopy and fecal occult blood test in 11 European countries. Endoscopy 2010; 42: 546-56.
31. Miglioretti DL, Rutter CM, Bradford SC, et al. Improvement in the diagnostic evaluation of a positive fecal occult blood test in an integrated health care organization. Med Care 2008; 46 (9, Suppl 1): S91-S96.
32. Singh H, Kadiyala H, Bhagwath G, et al. Using a multifaceted approach to improve the follow-up of positive fecal occult blood test results. Am J Gastroenterol 2009; 104: 942-52.
33. European Colorectal Cancer Screening Guidelines Working Group, von Karsa L, Patnick J, et al. European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication. Endoscopy 2013; 45: 51-9.
34. Hol L, van Leerdam ME, van Ballegooijen M, et al. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut 2010; 59: 62-8.
35. Vart G, Banzi R, Minozzi S,. Comparing participation rates between immunochemical and guaiac faecal occult blood tests: a systematic review and meta-analysis. Prev Med 2012; 55: 87-92.
36. Hassan C, Giorgi Rossi P, Camilloni L, et al. Meta-analysis: adherence to colorectal cancer screening and the detection rate for advanced neoplasia, according to the type of screening test. Aliment Pharmacol Ther 2012; 36: 929-40.
37. Rabeneck L, Rumble RB, Thompson F, et al. Fecal immunochemical tests compared with guaiac fecal occult blood tests for population-based colorectal cancer screening. Can J Gastroenterol 2012; 26: 131-47.
38. Brenner H, Tao S,. Superior diagnostic performance of fecal immunochemical tests for hemoglobin in a head-to-head comparison with guaiac based fecal occult blood test among 2235 participants of screening colonoscopy. Eur J Cancer 2013; 49: 3049-54.